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ABSTRACT 
There is a desire to engineer mammalian host cell lines to improve cell 
growth/biomass accumulation and recombinant biopharmaceutical protein production 
in industrially relevant cell lines such as the CHOK1 and HEK293 cell lines.  The 
over-expression of individual subunits of the eukaryotic translation factor eIF3 in 
mammalian cells has previously been shown to result in oncogenic properties being 
imparted on cells, including increased cell proliferation and growth and enhanced 
global protein synthesis rates. Here we report on the engineering of CHOK1 and HEK 
cells to over-express the eIF3i and eIF3c subunits of the eIF3 complex and the 
resultant impact on cell growth and a reporter of exogenous recombinant protein 
production. Transient over-expression of eIF3i in HEK293 and CHOK1 cells resulted 
in a modest increase in total eIF3i amounts (maximum 40% increase above control) 
and an approximate 10% increase in global protein synthesis rates in CHOK1 cells. 
Stable over-expression of eIF3i in CHOK1 cells was not achievable, most likely due 
to the already high levels of eIF3i in CHO cells compared to HEK293 cells, but was 
achieved in HEK293 cells. HEK293 cells engineered to over-express eIF3i had faster 
growth that was associated with increased c-Myc expression, achieved higher cell 
biomass and gave enhanced yields of a reporter of recombinant protein production. 
Whilst CHOK1 cells could not be engineered to over-express eIF3i directly, they 
could be engineered to over-express eIF3c, which resulted in a subsequent increase in 
eIF3i amounts and c-Myc expression. The CHOK1 eIF3c engineered cells grew to 
higher cell numbers and had enhanced cap- and IRES-dependent recombinant protein 
synthesis. Collectively these data show that engineering of subunits of the eIF3 
complex can enhance cell growth and recombinant protein synthesis in mammalian 
cells in a cell specific manner that has implications for the engineering or selection of 
fast growing or high producing cells for production of recombinant proteins. 
 
Keywords: cell engineering; mRNA translation; eukaryotic initiation factor eIF3; 
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INTRODUCTION 
There remains a desire to improve recombinant biopharmaceutical protein production 
from cultured mammalian cells, particularly in industrially relevant cell lines such as 
the CHOK1 and HEK293 cell lines [1-4].  Both these cell lines are particularly robust, 
amenable to genetic manipulations and have fast growth and proliferation rates that 
reflect their high protein synthetic capacity.  Improvements in vector design for 
recombinant protein production in mammalian cells are such that transcription is, in 
most cases, no longer considered rate-limiting for synthesis of these proteins.  
Initiation of translation, on the other hand, remains a tightly controlled, potentially 
rate-limiting step in mammalian cell protein synthesis.  A commonly adopted strategy 
in the large-scale production of therapeutic proteins in mammalian cells is to lower 
the culture temperature towards the end of rapid growth to mildly hypothermic levels 
(30-33oC) [5].  This has been found empirically to prolong the productive life of the 
culture by delaying apoptosis and nutrient depletion and, for some proteins, this 
strategy also improves the yield of correctly folded protein [6-8].   
Previously we have shown that although global protein synthesis is reduced during 
mammalian cell culture under mildly hypothermic conditions [9], recombinant mRNA 
levels can be increased at reduced temperature (27-32oC) due to increased stability 
and this, together with increased protein stability and enhancement of correct protein 
folding, can positively affect recombinant protein yields from mammalian cell lines 
[10].  In the course of a proteomic screen of protein synthesis changes occurring as 
cells are exposed to mildly sub-physiological temperatures, we identified eIF3i as one 
protein whose synthesis rate decreased significantly more than the global attenuation 
observed upon cooling and was then increased above the global increase upon 
rewarming [11]. This suggested that overexpression of eIF3i in CHO and HEK cells 
might enhance protein synthesis and compensate, at least in part, for the decrease in 
eIF3i under mildly hypothermic conditions. Other studies have also shown the 
relevance of translational control in mammalian cells to recombinant protein synthesis 
e.g. [12-16], hence demonstrating the potential for engineering translational control to 
enhance cellular growth and recombinant protein production capability. 
eIF3i is a component of the eukaryotic initiation factor 3 (eIF3) complex, the largest 
and most complex eukaryotic mRNA translation factor in terms of the number of its 
protein components.  Mammalian eIF3 contains a single copy of 12 different subunits, 
5 of which, a, b, c, g and i, are conserved and essential in vivo from yeasts to 
mammals [17-19].  Mass spectrometry of intact and salt-dissociated subcomplexes of 
eIF3 has provided a subunit interaction map of the complex [20] while several 
cryoEM studies [21-24] have delineated the overall shape of the complex, the locality 
of each of its subunits within this, and the positioning of the complex bound to the 
40S ribosomal subunit. The eIF3 complex forms a 5-lobed structure that binds to the 
solvent-exposed side of the 40S ribosomal subunit.  The various eIF3 subunits also 
contribute several additional binding sites for a number of other translation initiation 
factors [25, 26] and stimulate mRNA binding to the 40S [27].  The eIF3 complex can 
therefore be viewed as a scaffold that facilitates the bringing together, in the 
appropriate orientation, of key protein machinery components required to form the 
43S pre-initiation complex.  For cap-dependent translation binding between eIF3 and 
eIF4G promotes binding of the 43S complex with the eIF4F complex at the mRNA 
cap structure, resulting in the formation of the 48S preinitiation complex which can 
then scan to the start AUG codon [28].  There is also evidence that the association of 
eIF3 with the ribosome persists for the first few rounds of translation elongation and 
is thought to aid resumption of scanning after uORFs [29] and has been shown to play 
a role in translation termination [30].  
eIF3i is a 36 kDa protein containing 7WD repeat sequences which fold as a 7-bladed 
β-propeller [31, 32].  WD repeat proteins commonly form such rigid, circular 
structures that serve as a stable platform for protein-protein interactions.  The 
importance of this structure to eIF3i function has been confirmed in yeast by the 
severe effects on cell proliferation and global protein synthesis of mutations in the 
WD repeats of eIF3i, when compared with mutations elsewhere in the protein [33].  
However, based upon pull-down assays to determine subunit interactions within the 
eIF3 complex [34] and from the analysis of eIF3 subcomplexes by mass spectrometry 
[20], it appears that eIF3i is not centrally located within the complex and its 
association with the complex is labile.  Its only direct binding partner within the 
complex is the large scaffolding subunit eIF3b [33, 35] though there is evidence for 
the spectrin domain of eIF3a being involved in the formation of an a-b-i-g complex 
[36]   Although conserved and essential in vivo, eIF3i is not necessary for in vitro 
reconstitution of a pre-initiation complex that can scan to the start AUG [37].  The 
role of eIF3i within the eIF3 complex may therefore be more related to its mediating 
essential in vivo regulatory inputs into the translation initiation process rather than its 
being an essential structural component within the pre-initiation complex.  
eIF3i is one of 5 eIF3 components (a, b, c, h and i) that, when stably overexpressed in 
3T3 cells, induce an oncogenic phenotype with increased growth rate, increased 
protein synthetic rate, attenuated apoptosis and increased anchorage-independent 
growth [38].  However, in contrast to overexpression of the large core subunits a, b 
and c, stable overexpression of eIF3i does not upregulate the expression of the 
remaining eIF3 components.  Stable overexpression of eIF3c or eIFF3h selectively 
increases the translation of several mRNAs encoding proteins involved in cell growth 
and proliferation [38].  Expression of the encoded proteins is normally tightly 
regulated and/or restricted to specific parts of the cell cycle, so their overexpression 
leads to unregulated growth.  With the goal of enhancing protein synthesis in CHO 
and HEK cells, we here examine the effect of transient and stable overexpression of 
eIF3i in these cell lines.   
 
MATERIALS AND METHODS 
Cells and cell culture 
CHOK1, HEK293 and NIH3T3 cells were maintained as described elsewhere [11].  
The Invitrogen FlpIn system was used to generate stable CHOK1 and HEK293 cell 
lines according to manufacturer’s instructions.  In all cases cells were maintained in a 
5% CO2 environment. Cell proliferation was in some cases measured by growing cells 
in E-plates monitored using the xCELLigence System (ACEA Biosystems).  
Metabolic labelling with 35S-labelled amino acids was carried out in cysteine and 
methionine deficient DMEM (Sigma, D0422) containing Tran[35S] label (MP 
Radiochemicals) at 380 kBq/ml for 1 h.  Exposure to mildly hypothermic conditions 
(32 or 27oC), 24 h post-transfection, was for a further 24 h.  
Plasmids and transfections 
For transient over-expression of eIF3 subunits in mammalian cells, cDNAs encoding 
human eIF3 subunits were amplified by RT-PCR from HeLa cell RNA with primers 
(Table 1) flanked by suitable restriction sites for insertion into pcDNA3.1V5His 
(Invitrogen), with or without the natural stop codon, the latter permitting read through 
to a V5 tag on the distal vector arm, or, for generating stable cell lines, into pcDNA5-
FRT (Invitrogen).  The plasmids used in attempts to generate the CHO cell lines 
expressing HA-tagged human eIF3c or HA-tagged eIF3i were a kind gift from Dr. 
L.Zhang (University of California, Davis).  For transient overexpression of CCT 
oligomer, cDNAs encoding the 8 CHO CCT subunits were generated by RT-PCR 
(primers in Table 2) then inserted separately into the pcDNA3.1 vector.  Cells were 
transiently transfected 24 h after seeding 3 x 105 viable cells per well in 6-well plates, 
generally with 2 µg DNA per well using Optimem (Invitrogen) as a diluent and either 
Lipofectamine 2000 or LTX Lipofectamine with Plus reagent (Invitrogen) as 
transfection vehicle according to the manufacturer’s instructions.  For co-transfection 
of eIF3i and CCT subunits, 2 µg/well of eIF3i plasmid and 1 µg/well of each CCT 
plasmid were used.  Based on transfections with a pcDNA3.1 construct encoding 
GFP, typical transfection efficiencies of ~50% were obtained. 
Antibodies  
Proteins containing the V5 epitope were detected with a mouse monoclonal anti-V5 
(Sigma, V8012) and HA-tagged proteins with a rabbit anti-HA (Sigma H6908).  The 
rabbit polyclonals against eIF3i and eIF3h were sourced from Proteintech Group 
(11287-1-AP) and Sigma (AY50491), respectively.  Other anti-eIF3 subunit 
antibodies used were; anti-eIF3a, Cell Signaling (#2538); anti-eIF3b, Santa Cruz 
(sc16377); anti-eIF3c, Sigma (E6408).  A rabbit polyclonal against an N-terminal 
sequence of c-Myc was from Abcam (ab11917).  Subunit-specific rabbit polyclonals 
against individual CCT subunits and an antibody to RPL7a have been characterized 
elsewhere [39]. α-tubulin was detected with the TAT mouse monoclonal [40] which 
was a kind gift from Prof. Keith Gull (University of Oxford, UK).  β-actin was 
detected with the mouse monoclonal AC-15 (Sigma).  For western blot detection of 
pulldown proteins a protein A-HRP conjugate (Millipore) was used, otherwise anti-
rabbit, -mouse or -goat-HRP was used as secondary.  
Cell extraction, SDS-PAGE, western blotting, immunoprecipitation, 
immunofluorescence microscopy and luciferase assays 
Protein was extracted from mammalian cells after the cells had been washed with 
PBS at the appropriate temperature, by lysis in the culture flask or plate with ice-cold 
20 mM HEPES-NaOH, pH 7.2, containing 100 mM NaCl, 10 mM Na β-
glycerophosphate, 1% (w/v) Triton X-100, 50 mM NaF, 1 mM activated Na 
orthovanadate, 0.2 mM PMSF, 10 µg/ml leupeptin and 2 µg/ml pepstatin. SDS-PAGE 
and western blotting were undertaken as previously described [11].  
Immunoprecipitation under native conditions and immunofluorescence microscopy 
were undertaken as described by Roobol et al. [41].  For immunoprecipitation under 
denaturing conditions, the Triton-100 in the above lysis buffer was replaced by 1% 
NP40 + 0.5% deoxycholate + 0.1% SDS.  For luciferase measurement, cells were 
transfected with a pcDNA3.1 vector encoding firefly luciferase and 24 h later cells 
were lysed and luciferase activity determined using the SteadyLite Plus reagent 
according to manufacturer’s instructions.  To assess cap- and IRES-dependent 
translation, cells were transfected with the bicistronic reporter construct pRMF [42] 
with which cap-dependent translation was determined by Renilla luciferase activity 
while IRES-dependent translation was determined by Firefly luciferase activity using 
the Promega Dual-Glo kit.  Protein half-life determinations were as in [14].  Protein 
was quantified by the method of Bradford [43]. 
 
RESULTS 
The levels of transiently over-expressed eIF3i achievable in CHOK1 and HEK293 
cells are limited and transient over-expression does little to enhance protein 
synthesis. 
CHOK1 and HEK cells transiently transfected with eIF3i-pcDNA3.1 showed only a 
limited overall increase (30-40%) in total eIF3i expression 24 h after transfection 
(Fig. 1A and 1B). In the case of V5-tagged eIF3i, for which the endogenous and 
transfected eIF3i polypeptides could be resolved, the over-expression of eIF3i-V5 
suppressed expression of the endogenous protein to the extent that the total level of 
eIF3i was not greater than ~40% above the amount in mock transfected cells (Fig.1A 
and B).  Although the eIF3i transient over-expression amounts achieved were similar 
to that reported for NIH3T3 cells stably over-expressing eIF3i [38], in contrast to that 
stable cell line, CHOK1 cells transiently over-expressing eIF3i showed a relatively 
low enhancement (<20%) of protein synthesis as determined by [35S]-methionine 
incorporation (e.g. Fig. 1D).  We note, however, that the effect of overexpressed eIF3i 
on  [35S] incorporation in CHO cells was enhanced by exposing the cells to mild 
hypothermia (Supplementary Fig.1).  These data suggested that in CHOK1 cells 
transiently overexpressed eIF3i levels, though similar to those reported for stably 
transfected NIH 3T3 cells, had only a minor impact on enhancing protein synthesis. 
Collectively these data suggest that the total amount of eIF3i in both CHOK1 and 
HEK293 cells is tightly regulated. 
We have previously shown that eIF3i requires processing through the molecular 
chaperone CCT for its correct folding and found that a 3T3 cell line stably 
overexpressing eIF3i which showed enhanced cell growth and proliferation also had 
elevated levels of CCT [44].  In contrast, the CCT content of CHOK1 cells transiently 
transfected with eIF3i was unchanged compared to the mock transfected cells (Fig. 
1C) and co-transfection of eIF3i with the eight CCT subunits failed to enhance protein 
synthesis as measured by [35S]-methionine incorporation (Fig. 1D), though this latter 
may have been due to the heavy synthetic load imposed on the cell by overexpression 
of the eight CCT subunits together with eIF3i.  An explanation for these findings is 
that in CHOK1 cells transiently transfected with eIF3i, the CCT level was insufficient 
to support the correct folding of eIF3i, resulting in eIF3i protein that could not 
incorporate into the eIF3 complex.  
The intensity of immunostaining of transiently transfected cells with an eIF3i-specific 
antibody was greater than that of staining in surrounding non-transfected cells (Fig. 
2A). To determine whether exogenous eIF3i was capable of incorporation into the 
eIF3 complex, proteins in eIF3i and eIF3iV5 transfected cell extracts were 
immunoprecipitated with an antibody to eIF3i or to the V5 epitope and analysed by 
western blot (Fig. 2B).  The main proteins other than eIF3i and V5-tagged eIF3i (~40 
kDa) in the pulldowns were identified by immunoblot as eIF3b and to a lesser extent 
eIF3c.  However, it was noticeable that although the amount of eIF3i in the HEK 
eIF3i pulldown was less than in the CHO eIF3i pulldown, the co-precipitating eIF3b 
was higher in the HEK pulldown than in the CHO pulldown supporting the idea that 
human eIF3i incorporated into the HEK eIF3 complex better than into the CHO eIF3 
complex.  No eIF3a or RPS6 was detected in eIF3i pulldowns from either cell type 
transiently overexpressing eIF3i (Fig. 2B). These data suggest that the majority of the 
transiently overexpressed eIF3i did not incorporate into the eIF3 complex, though it 
might have incorporated to some extent into subcomplexes containing 3c or 3b.   
 
eIF3i can be stably overexpressed in HEK293 cells but not in CHOK1 cells 
As reported previously [38], a 3T3 cell line stably overexpressing eIF3i showed 
enhanced growth and protein synthesis levels at 37oC when compared with the vector 
control cell line.  Although we have successfully used the Flp-In system to generate a 
wide variety of stably over-expressing CHOK1 and HEK cell lines, including ones 
stably overexpressing eIF3c N-terminally tagged with the HA epitope and eIF3h [44], 
we were unable to detect any CHOK1 clones over-expressing 3i or HA-tagged eIF3i 
(Fig. 3A).   
The CHOK1 HA-eIF3c cell line we generated showed similar properties (Figs. 3B, 
3C and Supplementary 2 and 3) to those reported for the 3T3 HA-eIF3c cell line in 
that it showed enhanced growth rate, increased cap- and IRES-dependent translation 
and upregulated expression of eIF3i and c-Myc (Fig. 3C and Supplementary Fig. 3). 
The observed upregulation of the transcription factor c-Myc in the eIF3c over-
expressing cell line likely contributes to the enhanced proliferation rate of the CHOK1 
HA-eIF3c cell line. This shows that eIF3i expression levels can be elevated in 
CHOK1 cells when the cell also overexpresses the eIF3c subunit. Similarly, it has 
been shown in 3T3 cells [38] that overexpression of only eIF3a or eIF3b or eIF3c was 
sufficient to upregulate the amount of complete eIF3 complex whereas overexpression 
of eIF3i did not.   
Although the amount of overexpression achievable for eIF3i was also limited in 
HEK293 cells, stable clones were isolated in which eIF3i and eIF3iV5 expression was 
increased over the control cell line content (arrowed in Fig. 3A).  In addition, stable 
HEK cell lines were generated which overexpressed V5-tagged eIF3c, eIF3g, and 
eIF3h.  V5 pulldowns from 35[S]-labelled extracts of these cell lines identified several 
co-precipitating proteins in addition to the targeted protein (Fig. 3D).  Immunoblot 
analysis of the pulldowns (Fig. 3E) revealed eIF3 core components eIF3a and eIF3b 
along with RPS6, this latter being most prominently in the eIF3hV5 pulldown.  The 
eIF3iV5 pulldown however, did not show the presence of eIF3a and contained less 
eIF3b than the other cell line pulldowns.  This suggests that the exogenous eIF3i was 
either not fully incorporated into the eIF3 complex or that the exogenous eIF3iV5 was 
not accessible when incorporated into the complete eIF3 complex. However, a small 
amount of eIF3iV5 was incorporated into a subcomplex containing eIF3b.  The notion 
that exogenous eIF3i was not incorporated into the eIF3 complex was supported by a 
comparison of subunit availability to pulldown under native (N) and denaturing (D) 
conditions (Fig. 3E).  For the eIF3c, eIF3g and eIF3h cell lines considerably more 
protein was pulled down under denaturing conditions than under native conditions.  In 
contrast, the extent of eIF3i pulldown was similar under denaturing and native 
conditions.  This would be consistent with eIF3c, eIF3g and eIF3h epitopes being less 
exposed than the eIF3i epitope under native conditions.  This could arise either 
because the eIF3c, eIF3g and eIF3h epitopes were concealed by their incorporation 
into the eIF3 complex, or that correct folding of these subunits had obscured their 
epitopes.  The availability of the exogenous eIF3i epitope for pulldown could reflect 
its failure to incorporate into the eIF3 complex and/or failure to fold correctly when 
overexpressed. 
Nevertheless, a HEK cell line was established where the level of eIF3i expression was 
sufficiently elevated to impact on cell growth (Fig. 4A).  A HEK cell line expressing 
eIF3iV5 had a faster growth rate and increased overall cell biomass compared to the 
control cell line (Fig. 4A).  This 3iV5 HEK cell line also showed a significant 
increase in recombinant protein synthesis as measured by luciferase reporter protein 
expression (Fig. 4B).  c-Myc expression in the eIF3iV5 cell line was higher, and 
elevated earlier in the growth phase, than in the control and untagged eIF3i cell line 
(Fig. 4C).  Interestingly, the eIF3i expression levels were highest in the eIF3g-
overexpressing cell line (Fig. 4D), consistent with previous data which suggest that 
expression of eIF3g and eIF3i are strongly interdependent with eIF3g stabilising eIF3i 
[45].  The likely explanation for this is that the elevated level of eIF3g in the eIF3g 
HEK cell line provides a binding partner for correctly folded eIF3i on its release from 
the CCT molecular chaperone.  However, the generation of stable HEK cell lines 
over-expressing eIF3 subunits could not be attributed to an increase in CCT subunit 
levels in HEK cells.  Three CCT subunits that had identical CHO and human 
immunogenic sequences were investigated in this regard and were found similar in the 
two parental cell lines (Fig. 5A). 
 
The natural level of eIF3i is high in CHOK1 cells compared to HEK cells 
In the case of overexpression of eIF3i in CHOK1 and HEK293 cells, we found that 
even transient overexpression of this protein was quite limited and were unable to 
generate cell lines that stably expressed eIF3i alone above the natural level of this 
protein in CHOK1 cells.  We therefore hypothesised that the level of eIF3i was 
already sufficiently high in CHOK1 cells relative to the other cell lines that stable 
overexpression of this protein could not be achieved.  We investigated this by 
comparing ‘natural’ eIF3 subunit levels in CHOK1, NIH3T3 and HEK cells.  The 
antibodies used for these immunoblot investigations were all raised against human 
eIF3 subunit proteins or peptide sequences, and so any increase in immunoblot 
detection in the non-human cells indicated an increase in the detected protein.  A 
decrease in immunoblot detection relative to HEK cells could be accounted for by 
poor cross-reactivity of the antibody in the non-human cell lines; this probably 
accounts for the poor signal observed (Fig.5B) for the eIF3b antibody in CHOK1 
immunoblots.  The immunoblot data clearly show that, when compared to HEK or 
3T3 cells, CHOK1 cells express higher levels of eIF3i.  In contrast, eIF3a and eIF3c 
were only marginally increased in CHOK1 cells relative to HEK and 3T3 cells.  
These cell-type related differences in eIF3i levels were maintained at 32oC and, 
furthermore, eIF3i expression was increased at 32oC when compared with 37oC.  The 
increase in eIF3i expression at 32oC was in spite of its synthesis rate being lowered 
more than the average at 32oC [11] and may arise from improved folding of eIF3i at 
the lower temperature. This may also have arisen because, relative to eIF3a, eIF3b 
and eIF3c, eIF3i half-life at 37oC is short [44].  At 32oC, in general, protein half-lives 
are extended and this may allow accumulation of eIF3i at this temperature.   
 
DISCUSSION 
From these data we conclude that the CHOK1 cell line has relatively high levels of 
eIF3i.  As reported here, we show that the synthetic rate of exogenous eIF3i responds 
to existing eIF3i levels, and that this may account for our failure to stably overexpress 
this protein in CHOK1 cells.  The stable overexpression of eIF3i in 3T3 cells [38] 
promotes rapid growth phenotypes without upregulating the whole eIF3 complex and 
is dependent on phosphorylation by mTOR [46] for this activity.  The naturally high 
expression levels of the eIF3 subunit in CHOK1 and HEK293 cells compared to 3T3 
cells might be anticipated to amplify this linkage of nutrient and growth factor status 
to protein synthesis and growth rates and so contribute to the high protein synthetic 
capacity of these cells, a property that has made these cell line one of choice in the 
biopharmaceutical industry.  
A variety of approaches to improving recombinant protein production have been 
investigated that include exposure to mildly hypothermic conditions in the later stage 
of culture [2], using elements of the unfolded protein response to expand the ER and 
Golgi [47, 48], manipulation of cell signalling impinging on the process of translation 
[15] initiation and upregulation of translation initiation [38] and elongation [49] by 
manipulating levels of selected components of these processes.  In this report we have 
focussed on manipulating the levels of the translation initiation factors eIF3i and 
eIF3c, components of the large translation initiation factor eIF3, in the commercially 
relevant cell lines CHOK1 and HEK293 since it has been reported that overexpression 
of these translation initiation factors in 3T3 cells increased growth rate, increased 
protein synthetic capacity and delayed apoptosis [38].   
Although we demonstrate such objectives can be achieved, it is clear that endogenous 
cellular abundancies of specific eIF3 proteins should be taken into account.  This 
includes establishing and considering (1) whether the natural level of expression of 
the targeted protein limits its overexpression, (2) whether the overexpression requires 
up-regulation of other proteins as in the case of eIF3i overexpression being most 
effective when there is also upregulation of its binding partner eIF3g and (3) whether 
overexpression of a complete complex can be achieved by overexpression of just one 
of its components as is the case for overexpression of eIF3c but not so for 
overexpression of eIF3i.  These caveats, though here applied to the manipulation of 
eIF3 levels and functioning, may well apply to attempts to improve protein synthesis 
levels by manipulating the amounts of other proteins involved in translation initiation 
and elongation, particularly those that function in the context of a larger protein 
complex.    
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TABLE 1  Primers used for amplification of cDNAs encoding human eIF3 subunits 





3c forward TCGCCATGTCGCGGTTTTTC 
3c reverse TCAGTAGGCCGTCTGAGACTGC 
3g forward TTTGCGATGCCTACTGGAGACTTT
G 
3g reverse TTAGTTGGTGGACGGCTTGG 
3h forward AAGATGGCGTCCCGCAAGGAAG 
3h reverse TTAGTTGTTGTATTCTTGAAGAGC
C 






TABLE 2   Primers used for amplification of cDNAs encoding CHO cell CCT subunits 


































CCT8 reverse CGCGGATCCGAATTAATACGACTCACTATAGG 
  
FIGURE LEGENDS 
FIGURE 1.  Transient expression of eIF3i in CHOK1 cells is limited in extent 
and with little effect on global protein synthesis levels.   A. Immunoblot detection 
of eIF3i in CHOK1 and HEK cell lysates prepared from cells transiently transfected 
with eIF3i in pcDNA3.1V5 with (3iV5) or without (3i) read-through to the V5 tag (v, 
vector control) and maintained at 37oC for 24 h.  B. Immunoblots generated from 3 
independent experiments of the type shown in Fig. 1A were quantified with NIH 
ImageJ. (V) is the upper band of the 3iV5 samples in (A) and (i) the lower band of the 
3iV5 samples in (A) whilst V + I is the sum of these two bands in the immunoblots of 
V5-tagged 3i transfections. Error bars represent +/-1SD.   C. Co-expression of all 8 
components of the molecular chaperone CCT with eIF3i did not improve the level of 
eIF3i expression.  CHOK1 cells were co-transfected with 2 µg vector encoding 
human eIF3i and 1 µg each of vectors encoding each of the CHO cell CCT subunits 
with or without 35S-labelling for 1 h at the end of the 24 or 48 h period. Western blots 
of cell lysates were probed for the indicated CCT subunits, eIF3i and tubulin as a 
loading marker while (D) 35S-labelled samples were processed for scintillation 
counting, error bars represent +/- 1 SD from 3 measurements.    
 
FIGURE 2.  Most transiently overexpressed eIF3i in CHOK1 cells may not 
incorporate into the endogenous eIF3 complex.  A. Immunofluorescence detection 
of eIF3i in CHOK1 and HEK293 cells 24 h after transient transfection with eIF3i.  
Bar = 10 µ.  Side panel: western blots of equal amounts of cell lysate protein from 
CHOK1 and HEK cells probed for eIF3i. Arrowed, a protein weakly detected by the 
anti-eIF3i antibody on western blot.  B. Pulldowns (PDs) with the indicated antibodies 
were prepared from extracts of CHOK1 and HEK cells transiently transfected as 
indicated.  Western blots of the extracts and PDs were probed with the indicated 
antibodies.     
 
FIGURE 3.  Although stable CHO cell lines overexpressing eIF3i or HAeIF3i 
were not detected, a CHO cell line expressing HAeIF3c and HEK cell lines 
individually expressing several eIF3 subunits including an eIF3i over-expressing 
HEK cell line were successfully generated.  A. Cell line screens.  The HEK cell 
lines chosen for further investigation are arrowed.  B. A CHO cell line expressing 
HAeIF3c showed increased growth rate, error bars represent 1 SD from at least 3 
separate measurements.  Similar data was obtained for a second HAeIF3c clone 
investigated (Supplementary Fig. 2) and (C), increased cap- and IRES-dependent 
translation of the luciferase reporter pRMF (error bars represent 1  SD, 3 
measurements) and increased expression of eIF3c, eIF3i and c-Myc as determined by 
western blot (inset).  Supplementary Fig. 3 is a repeat of this experiment with a 
different cell line.  D. Western blot of extracts prepared from HEK cells stably 
expressing the indicated eIF3 subunit (v = vector control) probed for the V5 epitope 
or the indicated proteins.  E. Western blot of V5 PDs from extracts of HEK cells 
expressing the indicated V5-tagged eIF3 subunits and extracted under either native 
(N) or denaturing (D) conditions. 
 
FIGURE 4.  Characterisation of the HEK eIF3i over-expressing cell lines.  A. 
Cell growth of the indicated HEK cell lines as determined using the xCELLigence 
System.  B. The eIF3iV5 HEK cell line showed significantly increased cap-dependent 
translation of a firefly luciferase reporter compared with the control cell line. Error 
bars are +/- 1 SD and the difference between v and 3iV5 is statistically significant 
(p<0.00044).  C. Western blot detection of c-Myc in cell lysates of samples taken at 
sequential days in culture of the indicated cell lines.  D. Western blot of cell extracts 
of the indicated panel of stable eIF3x HEK cell lines probed for eIF3i and α-tubulin 
as a loading marker. 
 
FIGURE 5.  A. CHOK1 and HEK293 cells have similar CCT content.  B. CHO cells 
contain higher levels of eIF3i compared to 3T3 and HEK293 cells.  Western blots of 
lysates of the indicated cell lines probed for the indicated proteins.  
 
SUPPLEMENTARY FIGURE 1.  The effect of mild hypothermia on general 
protein synthesis in CHOK1 cells transiently transfected with vector (v) or eIF3i (i). 
 
SUPPLEMENTARY FIGURE 2.  A growth curve for a second CHOK1 clone 
expressing HAeIF3c.  Error bars are +/- 1SD from 4 measurements.     
 
SUPPLEMENTARY FIGURE 3.  A repeat of the experiment shown in Figure 3C 







We have engineered the overexpression of eIF3i and eIF3c in CHOK1 and HEK293 cells 
HEK293 cells overexpressing eIF3i had faster growth and increased c-Myc expression 
Direct stable overexpression of eIF3i in CHOK1 cells was not achievable 
Overexpression of eIF3c in CHOK1 cells resulted in an increase in eIF3i 
eIF3c overexpressing CHOK1 cells had enhanced recombinant protein synthesis 
 
